Dr Reddy's Laboratories (NSE:DRREDDY) Long-Term Debt : ₹3,800 Mil (As of Sep. 2024)

View and export this data going back to 2003. Start your Free Trial

What is Dr Reddy's Laboratories Long-Term Debt?

Dr Reddy's Laboratories's Long-Term Debt for the quarter that ended in Sep. 2024 was ₹3,800 Mil.

Dr Reddy's Laboratories's quarterly Long-Term Debt stayed the same from Mar. 2024 (₹3,800 Mil) to Jun. 2024 (₹3,800 Mil) and stayed the same from Jun. 2024 (₹3,800 Mil) to Sep. 2024 (₹3,800 Mil).

Dr Reddy's Laboratories's annual Long-Term Debt declined from Mar. 2022 (₹3,800 Mil) to Mar. 2023 (₹0 Mil) but then increased from Mar. 2023 (₹0 Mil) to Mar. 2024 (₹3,800 Mil).

Dr Reddy's Laboratories Long-Term Debt Historical Data

The historical data trend for Dr Reddy's Laboratories's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dr Reddy's Laboratories Long-Term Debt Chart

Dr Reddy's Laboratories Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Long-Term Debt

Get a 7-Day Free Trial

3,800.00

Dr Reddy's Laboratories Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Long-Term Debt	Get a 7-Day Free Trial															3,800.00	3,800.00	3,800.00	3,800.00	3,800.00

Dr Reddy's Laboratories (NSE:DRREDDY) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Dr Reddy's Laboratories Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Dr Reddy's Laboratories's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Dr Reddy's Laboratories Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dr Reddy's Laboratories Ltd (NSE:DRREDDY) » Definitions » Long-Term Debt

Traded in Other Exchanges

RDY:USA 500124:India RDDA:Germany RDDA:Germany R1DY34:Brazil

Address

8-2-337, Road No. 3, Banjara Hills, Hyderabad, TG, IND, 500 034

Website

https://www.drreddys.com

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Dr Reddy's Laboratories Headlines

No Headlines